Cargando…
Phosphodiesterase 4 Inhibitors in Allergic Rhinitis/Rhinosinusitis
Allergic rhinitis/rhinosinusitis (AR) is the most common allergic disease. It affects patients’ quality of life and may influence the severity of lower airway disease such as asthma. Therefore, its treatment is of great importance. AR is treated by a combination of effective approaches; however, in...
Autores principales: | Janosova, Viera, Calkovsky, Vladimir, Pedan, Heiko, Behanova, Estera, Hajtman, Andrej, Calkovska, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387511/ https://www.ncbi.nlm.nih.gov/pubmed/32792957 http://dx.doi.org/10.3389/fphar.2020.01135 |
Ejemplares similares
-
The Prevalence of Allergic Rhinitis in Patients with Chronic Rhinosinusitis
por: Bakhshaee, Mehdi, et al.
Publicado: (2014) -
Luteolin Attenuates Allergic Nasal Inflammation via Inhibition of Interleukin-4 in an Allergic Rhinitis Mouse Model and Peripheral Blood From Human Subjects With Allergic Rhinitis
por: Liang, Kai-Li, et al.
Publicado: (2020) -
Phosphodiesterase-4 Inhibitors for the Treatment of Inflammatory Diseases
por: Li, Heng, et al.
Publicado: (2018) -
Allergic Rhinitis, Asthma, and Rhinosinusitis: Diseases of the Integrated Airway
por: Meltzer, Eli O., et al.
Publicado: (2004) -
Phosphodiesterase-4 Inhibitors for Non-COPD Respiratory Diseases
por: Kawamatawong, Theerasuk
Publicado: (2021)